By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



601 North Parkcenter Drive
Suite 103
Santa Ana  California  92705  U.S.A.
Phone: 512-267-2430 Fax: n/a


BioCorRx, Inc. (OTC: BICX) is a healthcare solutions company on the leading edge of addiction treatment. The company has developed a treatment program that is used by various independently owned treatment centers throughout the United States to treat alcoholism and opioid addiction.

The program consists of two components:

BioCorRx, Inc. has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol or opioids for several months and as long as a year in some patients, depending on individual metabolism rates.

BioCorRx, Inc. also developed a counseling program that is tailored specifically to help those afflicted with addiction addicts prepare for life without abuse of their desired substance. Once a patient has received the implant, they are encouraged to enter the counseling program to maximize results.

BioCorRx, Inc.’s revolutionary addiction treatment program has a very high success rate as reported by patients in routine telephone and face to face interviews conducted by clinics using the program. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private counseling program without co-workers or family members knowing.




CEO: Brady Granier

Key Statistics

Ownership: Public

Web Site: BioCorRx
Symbol: BICX


Company News
BioCorRx  (BICX) Announces Beta Launch Of Mobile Application For Opioid And Alcohol Substance Use Disorder 9/13/2017 6:34:14 AM
BioCorRx  (BICX) Release: Company Retains Innovative Science Solutions To Guide FDA Regulatory Process For Its Naltrexone Products 1/13/2017 8:53:27 AM
BioCorRx  (BICX) To Host Corporate Update Webinar On Wednesday, October 12th At 2:00 p.m. Eastern Time 10/6/2016 9:58:40 AM
BioCorRx  (BICX) To Present At The Singular Research 11th Annual Best Of The Uncovereds Investment Conference September 22nd 9/20/2016 12:26:59 PM
BioCorRx  (BICX) Announces Update From First Joint Steering Committee Meeting For Injectable Naltrexone Product 9/16/2016 10:30:14 AM
BioCorRx  (BICX) Announces Agreement With Dr. David Gastfriend To Provide Strategic Initiative And Corporate Development Consulting 8/18/2016 9:57:16 AM
BioCorRx  (BICX) Announces License Agreement With TheraKine To Develop New Injectable Naltrexone Technology 8/4/2016 9:51:21 AM